Cathcart MC et al. |
Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer. |
2011 |
Mol. Cancer |
pmid:21388528
|
Oh SH et al. |
Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients. |
2011 |
Pharmacogenomics |
pmid:21449675
|
Akagi Y et al. |
Influence of nonsteroidal anti-inflammatory drugs on the antiplatelet effects of aspirin in rats. |
2011 |
Biol. Pharm. Bull. |
pmid:21415533
|
Cherdon C et al. |
BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthase. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21397034
|
Yano T et al. |
Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury. |
2011 |
Cardiovasc. Res. |
pmid:21169294
|
Saihkay HN et al. |
Validating 123I-metaiodobenzylguanidine as a platelet marker for non-invasive imaging in rabbits. |
2011 Jan-Feb |
J Pharmacol Toxicol Methods |
pmid:20646985
|
Brainard BM et al. |
Effects of clopidogrel and aspirin on platelet aggregation, thromboxane production, and serotonin secretion in horses. |
2011 Jan-Feb |
J. Vet. Intern. Med. |
pmid:21143302
|
Alcott CJ et al. |
Clinical and immunomodulating effects of ketamine in horses with experimental endotoxemia. |
2011 Jul-Aug |
J. Vet. Intern. Med. |
pmid:21745244
|
Chakroun T et al. |
The cyclooxygenase-1 C50T polymorphism is not associated with aspirin responsiveness status in stable coronary artery disease in Tunisian patients. |
2011 Jul-Aug |
Genet Test Mol Biomarkers |
pmid:21434767
|
Thomason J et al. |
Platelet cyclooxygenase expression in normal dogs. |
2011 Sep-Oct |
J. Vet. Intern. Med. |
pmid:21985141
|
Jarvis GE et al. |
A role for adhesion and degranulation-promoting adapter protein in collagen-induced platelet activation mediated via integrin α(2) β(1). |
2012 |
J. Thromb. Haemost. |
pmid:22103309
|
Larsen SB et al. |
Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction. |
2012 |
Thromb. Haemost. |
pmid:22534977
|
Li C et al. |
Reversal of the anti-platelet effects of aspirin and clopidogrel. |
2012 |
J. Thromb. Haemost. |
pmid:22268852
|
Rocca B et al. |
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes. |
2012 |
J. Thromb. Haemost. |
pmid:22471290
|
Lee JJ et al. |
Morusinol extracted from Morus alba inhibits arterial thrombosis and modulates platelet activation for the treatment of cardiovascular disease. |
2012 |
J. Atheroscler. Thromb. |
pmid:22472211
|
Bruegel M et al. |
Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients. |
2012 |
Crit. Care Med. |
pmid:22511130
|
Totani L et al. |
Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse. |
2012 |
Thromb. Haemost. |
pmid:22436970
|
Ajamieh H et al. |
Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. |
2012 |
J. Gastroenterol. Hepatol. |
pmid:22432744
|
Salama MM et al. |
Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors. |
2012 |
J Clin Pharm Ther |
pmid:23121257
|
Yokoyama H et al. |
Theoretical investigation of aspirin dosage regimen to exhibit optimal antiplatelet effects and decrease risk of upper gastrointestinal lesions. |
2012 |
Biol. Pharm. Bull. |
pmid:23047244
|